NCT06433570Not yet recruiting
Detection of Krupple Like Factor -1(KLF1/ EKLF) DNA Mutations in Beta Thalassemia Patients
Source: ClinicalTrials.gov · Last updated 29 May 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
* Detection of KLF1 gene mutations in patients with beta thalassemia considering the alpha and beta molecular status of these patients. * Study the relation between genotypic mutational status of KLF1 mutation with the level of Hb F and Hb A2 in the patients of beta thalassemia.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 23 May 2024
- Start date
- Jun 2024
- Primary completion date
- Jun 2027
- Lead sponsor
- Assiut University
- Diseases
- Thalassaemia
- NCT number
- NCT06433570
What you commit to
- Study type: Observational
- Planned participants: 100
- From Jun 2024 to the primary completion date, Jun 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients on Hydroxyurea therapy
Other
- Patients with any other type of haemolytic anaemias.
Who the study is looking for
- Patients with β-thalassemia (intermedia and major) of both genders at any age
Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.